Public Health Webinar Series on Blood Disorders
CDC’s Division of Blood Disorders (DBD) is proud to offer its Public Health Webinar Series on Blood Disorders. The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. We invite you to join us in this series.
Archives for 2019
June 6, 2019
Guy Young, MD
Director, Hemostasis and Thrombosis, Center at Children’s Hospital Los Angeles
Associate Professor of Pediatrics, University of Southern California Keck School of Medicine
In this webinar, Dr. Young provides an overview to new and upcoming treatments for hemophilia. He also briefly review the data from published gene therapy trials. He will also discuss some of the unique challenges that new treatments raise for clinicians and provide some potential solutions to those challenges.
March 7, 2019
Neil A. Goldenberg, MD, PhD
Professor of Pediatrics and Medicine, Johns Hopkins University School of Medicine
Director, Johns Hopkins Medicine Pediatric Thrombosis Program, St. Petersburg, FL and Baltimore, MD
Director of Research, Johns Hopkins All Children’s Hospital and Chief Research Officer, All Children’s Research Institute, St. Petersburg, FL
In this webinar, Dr. Goldenberg will discuss the key aspects of VTE in children, including risk factors, diagnosis, treatment, outcomes, prognostic factors, and prevention. He will also review the recently released guidelines on the treatment of pediatric venous thromboembolism, published by the American Society of Hematology.
February 28, 2019
Janet L. Kwiatkowski, MD, MSCE
Director, Thalassemia Center of Children’s Hospital of Philadelphia
Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania
In this webinar, Dr. Kwiatkowski provides an overview of current, recommended treatments for people with thalassemia, with an emphasis on transfusion-dependent thalassemia. She discusses best practices in transfusion, as well as monitoring and treatment of iron overload.
Archives for 2018
December 6, 2018
Michael B. Streiff, MD, FACP
Associate Professor of Medicine and Pathology
Associate Faculty, Armstrong Institute for Patient Safety and Quality
Medical Director, Johns Hopkins Anticoagulation Management Service and Outpatient Clinics
Medical Director, Special Coagulation Laboratory
Senior Consultant, Johns Hopkins Comprehensive Hemophilia Treatment
Johns Hopkins Medical Institutions, Baltimore, Maryland, and Chair, Medical and Scientific Advisory Board, National Blood Clot Alliance
Scientific Update on Venous Thromboembolism Prophylaxis in Orthopedic Surgery: Making Sense of the Recommendations
In this webinar, Dr. Streiff provides an overview of current studies on VTE prophylaxis for orthopedic surgery and discusses potential future directions in orthopedic thromboprophylaxis.
October 11, 2018
Jeffrey Weitz, MD
Professor of Medicine and Biochemistry and Biomedical Sciences, McMaster University
Executive Director of Thrombosis and Atherosclerosis Research Institute
In this webinar, Jeffrey Weitz, MD, discusses what people need to know about their increased risk for venous thromboembolism during and after a stay in the hospital.
September 20, 2018
Brian Boylan, MS
Research Biologist, Division of Blood Disorders
Hemostasis Laboratory Branch
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention
In this webinar, Mr. Boylan describes technical improvements in the manufacturing process for new recombinant factor VIII and factor IX treatment products for people with hemophilia. He then examines inhibitor testing methods within the context of the use of these new hemophilia treatment products.
March 15, 2018
Michael Cassidy, MD
Assistant Professor of Surgery
Boston University School of Medicine
Section of Surgical Oncology
Boston Medical Center
Perioperative Venous Thromboembolism: Risk Assessment and Risk-Stratified Prophylaxis for Surgical Patientsexternal icon
In this webinar, Michael Cassidy, MD, discusses what is known about risk factors, risk assessment, and perioperative VTE prophylaxis, including extended postoperative prophylaxis. He also shares the outcomes of a standardized program of risk stratification and risk-based VTE prophylaxis regimens.
February 22, 2018
Barbara A. Konkle, MD
Associate Chief Scientific Officer
Director, Hemostasis, Platelet Immunology and Genomics Laboratory
Associate Director, Washington Center for Bleeding Disorders
Professor of Medicine, University of Washington
In this webinar, Dr. Konkle describes the hemophilia genomics project called My Life, Our Future (MLOF). She shares results of genetic analyses of participant samples and discusses potential research advances through the MLOF Research Repository.
For more information on the webinar series, please contact Cindy Sayers at firstname.lastname@example.org.